PFG Advisors increased its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 31.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,607 shares of the company’s stock after buying an additional 5,824 shares during the period. PFG […]
Motive Wealth Advisors raised its stake in AbbVie Inc. (NYSE:ABBV – Get Rating) by 38.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,098 shares of the company’s stock after buying an additional 586 shares during the period. Motive Wealth Advisors’ holdings in AbbVie […]
Arbor Investment Advisors LLC lifted its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 30.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,986 shares of the company’s stock after buying an additional 698 shares during the quarter. Arbor Investment Advisors […]
Humankind Investments LLC trimmed its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 8.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 13,898 shares of the company’s stock after selling 1,321 shares during the quarter. AbbVie makes up approximately 1.0% of Humankind Investments LLC’s portfolio, making the stock its 16th biggest position. […]
SevenBridge Financial Group LLC boosted its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 0.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,578 shares of the company’s stock after acquiring an additional 155 shares during the period. SevenBridge Financial Group […]